Philippe Lavielle appointed Chairman of the Board of Directors

Libourne – 13 September 2016 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has announced the appointment of Philippe Lavielle as Chairman of the Board of Directors.

56 years of age and married with three children, Philippe Lavielle holds a Masters from HEC in Paris and a diploma from the International Institute for Management Development (IMD).

An expert in the management of innovative businesses, primarily within the biotech sector, he notably spent more than 20 years with Genencor, one of the leading producers of industrial enzymes and now part of DuPont. At Genencor he worked as Vice President and BU Manager before being named Executive Vice President in charge of Business Development.

Following this, in 2011 Philippe Lavielle was appointed President and CEO of VIRDIA, a company specializing in the development of innovative industrial solutions in the production of biofuels and bioproducts, before moving on to various directorships for California-based start-ups from July 2014. Philippe Lavielle has been a director at Fermentalg since May 2016[1].

Philippe Lavielle takes over from Pierre Calleja, founder of Fermentalg, who has resigned from all of his mandates.

Philippe Lavielle said: "I would first and foremost like to thank Pierre Calleja on behalf of all of Fermentalg's directors for his role in the successful transition of the company over the past 9 months, which has led to the implementation of a new governance structure to support the potential and ambitions of our company. Since my appointment as director last May, a great deal of work has been accomplished in close collaboration with General Management in order to clearly lay out the path to the strategic objectives in place since the start of 2016. Today, my goal is to invest more of my time and energy to developing Fermentalg's strategic reach and ensuring its management team has all of the support it needs."

Pierre Calleja added: "I am extremely proud of just how far Fermentalg has come since I founded the company in 2009. As it undertakes a new chapter with the industrialization and commercialization of its first products, the time has come for me to focus on other projects. With the appointment of Philippe Lavielle as Chairman of the Board of Directors, I am convinced that the company has everything it takes to succeed."

About Fermentalg

Based in Libourne (Gironde), Fermentalg is an industrial biotechnology company and a global leader in the production of oils and proteins derived from the fermentation of microalgae. Its primary markets are the human nutrition and animal feed sectors and the green chemistry industry. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.

 

Press Relations:
 

Investor Relations:


 
 


ACTUS finance & communication

Alexandra Prisa

Tel: +33 (0)1 53 67 36 90

[email protected]
ACTUS finance & communication

Jérôme Fabreguettes-Leib

Tel: +33 (0)1 53 67 36 78

[email protected]

Source: Actusnews